The role of splanchnic congestion and the intestinal microenvironment in the pathogenesis of advanced heart failure.


Journal

Current opinion in supportive and palliative care
ISSN: 1751-4266
Titre abrégé: Curr Opin Support Palliat Care
Pays: United States
ID NLM: 101297402

Informations de publication

Date de publication:
03 2019
Historique:
pubmed: 15 1 2019
medline: 18 12 2019
entrez: 15 1 2019
Statut: ppublish

Résumé

Right-sided heart failure, which is often present in the setting of advanced heart failure, is associated with cardiac cachexia, the cardiorenal syndrome, and adverse outcomes. Improved understanding of venous congestion of the splanchnic circulation, which may play a key role in the pathogenesis of right-sided heart failure, could lead to novel therapeutics to ameliorate heart failure. Here we provide an overview of right-sided heart failure, splanchnic hemodynamics, fluid homeostasis, and the intestinal microenvironment. We review recent literature to describe pathophysiologic mechanisms and possible therapeutics. Several possible mechanisms centered around upregulation of sodium-hydrogen exchanger-3 (NHE3) may form a causal link between right ventricular dysfunction, splanchnic congestion, and worsening heart failure. These include an anaerobic environment in enterocytes, resulting in reduced intracellular pH; increased sodium absorption by the gut via NHE3; decreased pH at the intestinal brush border thus altering the gut microbiome profile; increased bacterial synthesis of trimethylamine N-oxide; and decreased bacterial synthesis of short-chain fatty acids causing abnormal intestinal barrier function. Splanchnic congestion in the setting of right-sided heart failure may serve an important role in the pathogenesis of advanced heart failure, and further exploration of these mechanisms may lead to new therapeutic advances.

Identifiants

pubmed: 30640740
doi: 10.1097/SPC.0000000000000414
pmc: PMC6366455
mid: NIHMS1518772
doi:

Substances chimiques

Fatty Acids, Volatile 0
Methylamines 0
Sodium-Hydrogen Exchanger 3 0
Sodium 9NEZ333N27
trimethyloxamine FLD0K1SJ1A

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

24-30

Subventions

Organisme : NHLBI NIH HHS
ID : R01 HL107577
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL127028
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL140731
Pays : United States

Références

Cell Host Microbe. 2015 May 13;17(5):662-71
pubmed: 25865369
Curr Hypertens Rep. 2017 Apr;19(4):25
pubmed: 28315048
Int J Cardiol. 2012 May 17;157(1):80-5
pubmed: 21190739
Curr Opin Clin Nutr Metab Care. 2008 Sep;11(5):632-9
pubmed: 18685461
Circ Res. 2015 Jan 30;116(3):448-55
pubmed: 25599331
J Am Coll Cardiol. 2014 May 6;63(17):1809-10
pubmed: 24315902
Dig Dis Sci. 2016 Dec;61(12):3621-3626
pubmed: 27655104
N Engl J Med. 2005 Jan 6;352(1):20-8
pubmed: 15635109
J Clin Invest. 1994 Jan;93(1):106-13
pubmed: 8282777
J Am Heart Assoc. 2016 Jun 10;5(6):
pubmed: 27287696
Cell. 2016 Mar 24;165(1):111-124
pubmed: 26972052
Clin Chem. 2017 Jan;63(1):297-306
pubmed: 27864387
Proc Natl Acad Sci U S A. 2013 Mar 12;110(11):4410-5
pubmed: 23401498
Am J Physiol Cell Physiol. 2000 Apr;278(4):C629-37
pubmed: 10751311
Am J Physiol Gastrointest Liver Physiol. 2002 May;282(5):G776-84
pubmed: 11960774
Am J Physiol Gastrointest Liver Physiol. 2002 Jul;283(1):G51-6
pubmed: 12065291
Arch Intern Med. 2011 Jun 27;171(12):1061-8
pubmed: 21321288
Int J Obes (Lond). 2013 Feb;37(2):216-23
pubmed: 22410962
ESC Heart Fail. 2018 Oct;5(5):977-984
pubmed: 30088346
Pflugers Arch. 2009 Mar;457(5):1079-91
pubmed: 18758809
Eur J Heart Fail. 2005 Jun;7(4):485-9
pubmed: 15921784
Curr Drug Metab. 2009 Jan;10(1):22-8
pubmed: 19149510
J Am Coll Cardiol. 2014 Nov 4;64(18):1908-14
pubmed: 25444145
N Engl J Med. 2017 Sep 21;377(12):1119-1131
pubmed: 28845751
Aliment Pharmacol Ther. 2008 Jan 15;27(2):104-19
pubmed: 17973645
J Am Coll Cardiol. 2016 Jun 7;67(22):2620-8
pubmed: 27256833
J Am Coll Cardiol. 2009 Feb 17;53(7):589-596
pubmed: 19215833
Circulation. 2017 Apr 25;135(17):1671-1673
pubmed: 28438808
Circ Heart Fail. 2016 Jan;9(1):e002314
pubmed: 26699388
J Clin Invest. 2016 Oct 3;126(10):3680-3688
pubmed: 27500494
Aliment Pharmacol Ther. 2009 May 1;29(9):992-9
pubmed: 19210289
Am J Physiol Gastrointest Liver Physiol. 2008 Nov;295(5):G909-19
pubmed: 18801914
World J Gastroenterol. 2015 Nov 21;21(43):12322-33
pubmed: 26604640
Circulation. 2017 Mar 7;135(10):964-977
pubmed: 27927713
Eur J Echocardiogr. 2009 Aug;10(6):733-7
pubmed: 19443468
J Card Fail. 2014 May;20(5):319-26
pubmed: 24530944
Surgery. 2004 Aug;136(2):375-83
pubmed: 15300204

Auteurs

Vincenzo B Polsinelli (VB)

Department of Medicine, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.

Lara Marteau (L)

Division of Cardiology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.

Sanjiv J Shah (SJ)

Division of Cardiology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH